Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study.
Saved in:
| Title: | Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study. |
|---|---|
| Authors: | Gehin, JE1,2 (AUTHOR) johgeh@ous-hf.no, Warren, DJ1 (AUTHOR), Syversen, SW3 (AUTHOR), Lie, E3,4 (AUTHOR), Sexton, J3 (AUTHOR), Loli, L5 (AUTHOR), Wierød, A6 (AUTHOR), Bjøro, T1,2 (AUTHOR), Kvien, TK2,3 (AUTHOR), Bolstad, N1 (AUTHOR), Goll, GL3 (AUTHOR) |
| Source: | Scandinavian Journal of Rheumatology. Nov 2021, Vol. 50 Issue 6, p445-454. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03009742 |
|---|---|
| DOI: | 10.1080/03009742.2021.1875040 |
